%0 Journal Article
%K Angiogenesis Inhibitors
%K Antineoplastic Agents
%K Apoptosis
%K Cell Adhesion Molecules
%K Clinical Trials, Phase II as Topic
%K Clinical Trials, Phase III as Topic
%K Cytokines
%K Drug Screening Assays, Antitumor
%K Endothelium, Vascular
%K Humans
%K Immunologic Factors
%K Interferon-gamma
%K Interleukin-2
%K Killer Cells, Natural
%K Lenalidomide
%K Lymphocyte Activation
%K Multiple Myeloma
%K Myelodysplastic Syndromes
%K Neoplasms
%K T-Lymphocyte Subsets
%K Thalidomide
%B The AAPS journal
%D 2005
%G eng
%N 1
%P E14-9
%R 10.1208/aapsj070103
%T Properties of thalidomide and its analogues: implications for anticancer therapy.
%V 7
%1 http://www.ncbi.nlm.nih.gov/pubmed/16146335?dopt=Abstract
%8 2005 Mar 22